Aquablation Robotic Therapy
Customize your policy alerts
Sign up for all summacare policy alerts
Know when summacare releases new policies or updates existing guidance.
Monitor payer policy activity
Coverage and medical necessity for transurethral waterjet/Aquablation therapy for lower urinary tract symptoms caused by benign prostatic hyperplasia in Commercial and Medicare members, including authorization requirements, eligibility criteria, limitations, exclusions, and investigational procedures.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.